Voyager Therapeutics Inc.

NASDAQ: VYGR · Real-Time Price · USD
3.73
0.01 (0.27%)
At close: Aug 15, 2025, 3:59 PM
3.77
0.83%
After-hours: Aug 15, 2025, 07:35 PM EDT

Voyager Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-33.38M -31.02M -34.49M -9.04M -10.14M -11.33M 56.4M -25.9M -22.21M 124.04M -23.63M 17.62M -19.09M -21.32M 5.71M -25.14M -30.12M -21.65M
Depreciation & Amortization
-724K 1.01M 1.01M 1.13M 1.39M 1.2M 1.33M 945K 1.09M 1.07M 834K 1.34M 1.2M 2.81M 1.48M 1.22M 1.19M 1.27M
Stock-Based Compensation
4.13M 3.67M 3.74M 3.43M 4.04M 3.57M 3.04M 2.88M 2.67M 2.56M 2.35M 2.19M 2.49M 2.32M 1.65M 2.08M 3.99M 3.6M
Other Working Capital
10.52M -10.52M -1.63M -5.76M -21.59M -19.87M -2.97M -962K -1.5M 19.8M -3.38M -27.38M -678K 49.44M 2.92M -549K -332K -3.76M
Other Non-Cash Items
-15.1M 253K -1.48M -1.87M -518K -815K -1.76M -1.79M 72K 27K 384K -25K -2.49M 21K 25K 111K 1.42M -3.88M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 111K 102K
Change in Working Capital
11.81M -11.81M 16.69M -21.62M -26.36M 66.14M -82.78M 2.81M 17.54M -4.14M 7.82M -37.34M -605K 50.59M 2.33M 1.01M 694K -740K
Operating Cash Flow
-33.26M -37.9M -14.53M -27.97M -31.58M 58.77M -23.76M -21.05M -835K 123.56M -12.24M -16.21M -18.48M 34.43M 11.2M -20.71M -22.72M -21.29M
Capital Expenditures
-1.1M -658K -155K -258K -967K -2.14M -755K -782K -1.21M -509K -933K -278K -1.24M -38K -347K -660K -227K -375K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -27.59M 157.52M 23.45M n/a n/a n/a n/a n/a -2.46M n/a n/a n/a
Purchase of Investments
-37.87M -76.92M -131.02M -40.81M -90.01M -203.85M -28.99M -166.52M -28.45M n/a n/a n/a -34.89M -19.96M -15.12M n/a n/a n/a
Sales Maturities Of Investments
40.9M 118.78M 103.97M 105.42M 55.03M 109.93M 56.58M 9M 5M 15M 15M 35M n/a n/a 10M 15M 22.63M 35M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 27.59M -157.52M -23.45M n/a 15M 35M -34.89M -19.96M 2.46M 15M 22.63M 35M
Investing Cash Flow
1.93M 41.2M -27.2M 64.35M -35.94M -96.06M 26.83M -158.3M -24.66M 14.49M 14.07M 34.72M -36.13M -20M -5.46M 14.34M 22.41M 34.63M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
434K n/a n/a n/a n/a n/a n/a n/a n/a n/a 249K n/a n/a n/a 584K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
79K 82K 574K 14K 571K 78K 460K 331K 1.55M 185K 276K 15K 807K 12K 227K n/a 357K 28K
Financial Cash Flow
513K 82K 574K 14K 571K 112.86M 460K 331K 1.55M 31.31M 276K 15K 807K 12K 227K n/a 357K 28K
Net Cash Flow
-30.82M 3.39M -41.16M 36.4M -66.95M 75.56M 3.53M -179.02M -23.95M 169.36M 2.1M 18.53M -53.81M 14.44M 5.96M -6.37M 45K 13.36M
Free Cash Flow
-34.37M -38.55M -14.68M -28.23M -32.55M 56.63M -24.52M -21.83M -2.04M 123.06M -13.18M -16.48M -19.73M 34.39M 10.85M -21.37M -22.94M -21.67M